The solution to clinical trials nightmare
Let me briefly introduce myself due to the nature of the article am about to enlighten my readers on.
Am Mohammed Agashi Haruna a final year medical student at Bayero University kano Nigeria. Am the chairman covid-19 vaccines advocacy northwestern region Nigeria medical student association. With this brief introduction I want to point out to my dear readers that I have first hand knowledge and information on what Clinicals trials are and what in entails.
The world as a whole has never been challenged disease wised like we have witness in the past couple of months due to the emergence of covid-19 and other diseases.
No better time to talk about clinical trials and what it entails like now.
With the development of sophisticated technologies and medical approaches in dealing with emerging and re-emerging diseases the life expectancy for man has greatly improved but still yet the challenges keeps coming and mana has got to keep up with what’s required or its survival.
When we talk about clinical trials it simply means observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on dosage, safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial — their approval does not mean the therapy is ‘safe’ or effective, only that the trial may be conducted.
Clinical trials can be divided into phase 1,2,3,4 and post marketing phase.
Phase 1 simply is laying emphasis on safety and dosing level, phase 2 simply is more concerned about its efficacy and side effects while phase 3 is to bring up more prove and elaborate studies on the efficacy and side effects, phase 4 is usually conducted after the drugs has been used for a novel treatment and has been approved and the marketing phase deals with long term complications of the particular drugs and products.
The following are stakeholders of Clinicals trails. This groups of committees or people need to be present before a clinical trials can be said to have taken place, in the absent of any a clinical trials would said to have failed, the following are the stakeholders:
-CONTRACT RESEARCH ORGANIZATION
-REGULATORS(independent ethics committee)
-VOLUNTEERS OR PATIENTS
All these committees or group of individual are required for the successful organization of a clinical trial.
With all this little summary of what a clinical trial look like you will agree with me that it takes a lot to be able to achieve this especially when it comes to data management and being able to do a successful clinical trial and also all the bureaucracy associated with it especially its approval and so on and you will also agree with me that to be able to pull these kind of project there is a high chance that Data will be mismanagemed, misrepresented or lost, putting all of the cost and effort that has been dedicated to the project at risk, because one small data error can cause catastrophic damage to the production process. So with this in mind it’s an honor and privilege to introduce to you the most needed and sought after solutions of all this problems which is TRIALL!
Triall is a projects built on blockchain technology, and we all know the efficiency and integrity of the blockchain technology due to its decentralized format and superior technological innovations now what TRAILL has done is to use that property of blockchain technology, bringing Web 3.0 to medical research by developing a digital ecosystem of blockchain-integrated software solutions. The blockchain infrastructure makes medical data tamper-resistant. It also enables secure and efficient connections between the many isolated systems and individuals involved in clinical research.
Now the second most impressive thing about these platform is the Verial eTMF (electronic trial master file) these is one aspect of triall that support researchers during clinical trials documentations. With all this and with the facts that medical researchers and clinical trials is something that would be a thing of regular occurrence due to the time we are living in now, so this is a project now one should be left out from because it’s success is really understated.
The Triall has two tokens system TRL and T-CRED.
For more information visit the following site:
Note that these article should not be consider as a financial advise it’s a sponsored article written for a bounty reward by a bounty hunter.